Post-effective amendment to a registration statement that is not immediately effective upon filing

Subsequent Events (Details)

v3.22.1
Subsequent Events (Details)
$ / shares in Units, € in Thousands
12 Months Ended
Mar. 22, 2022
USD ($)
shares
Feb. 28, 2022
Feb. 01, 2022
USD ($)
shares
Feb. 01, 2022
EUR (€)
shares
Jan. 14, 2022
USD ($)
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
Feb. 02, 2022
shares
Jan. 13, 2022
$ / shares
Jul. 19, 2021
$ / shares
Subsequent Events (Details) [Line Items]                    
Shares issued (in Shares) | shares           7,000        
Value of debt conversion           $ 6,047,000        
Accrued interest           $ 26,538,000 $ 4,191,000      
Subsequent Event [Member]                    
Subsequent Events (Details) [Line Items]                    
Shares of warrant (in Shares) | shares               4,900,000    
Class of Warrant or Right, Waiver Termination Period With Prior Written Notice   61 days                
Grant of RSUs, description         the Company granted 1,741,659 RSUs to its management, employees, and outside advisors available under the 2020 Incentive Award Plan. The vesting period of these grants range from 1 to 4 years. Please refer to Note 15 for more details on the 2020 Incentive Award Plan.          
Cansativa [Member]                    
Subsequent Events (Details) [Line Items]                    
Percentage of diluted basis           9.00% 14.22%      
Cansativa [Member] | Subsequent Event [Member]                    
Subsequent Events (Details) [Line Items]                    
Shares of investment (in Shares) | shares     1,586 1,586            
Investment of cansativa shares (in Euro) | €       € 2,300            
Equity ownership amount     $ 2,055,000              
Percentage of diluted basis     9.00% 9.00%            
Convertible Notes Due 2024 [Member]                    
Subsequent Events (Details) [Line Items]                    
Capital market value of per shares (in Dollars per share) | $ / shares                   $ 7
Convertible Notes Due 2024 [Member] | Subsequent Event [Member]                    
Subsequent Events (Details) [Line Items]                    
Capital market value of per shares (in Dollars per share) | $ / shares                 $ 2.2  
Equity Distribution Agreement [Member] | Subsequent Event [Member]                    
Subsequent Events (Details) [Line Items]                    
Shares of investment (in Shares) | shares 2,801,997                  
Aggregate offering price amount         $ 50,000,000          
Common rate of exceed price         3.00%          
Net proceeds $ 3,316,000                  
At-the Market [Member] | Subsequent Event [Member]                    
Subsequent Events (Details) [Line Items]                    
Aggregate offering price amount         $ 18,000,000          
Common Stock [Member] | Convertible Notes Due 2024 [Member]                    
Subsequent Events (Details) [Line Items]                    
Shares issued (in Shares) | shares           7,000        
Value of debt conversion           $ 15,000        
Accrued interest           $ 3,500,000        
Common Stock [Member] | Convertible Notes Due 2024 [Member] | Subsequent Event [Member]                    
Subsequent Events (Details) [Line Items]                    
Convertible note payable $ 16,395,000